Rose Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Eileen Francis

Eileen Francis is a reporter for “The Tan Sheet,” where she follows news on OTC drug and nutritional product manufacturing, regulation, legislation, finance and research. She previously served as a reporter and editor of “The Rose Sheet,” IBI’s source for in-depth coverage of the cosmetics industry. Early in her career, Eileen worked in public relations and as a writer for a lobbying firm. Outside of IBI, her freelance work includes articles on business, art and travel.
Advertisement
Set Alert for Articles By Eileen Francis

Latest From Eileen Francis

Kratom Industry GMPs Target Swaying FDA By Exceeding Agency Standards

“We want to show that the kratom industry is maturing, that people want to do the right thing,” says AKA Chairman Dave Herman. The standards go “well beyond” FDA's minimum GMP requirements for dietary supplements, AKA says.

United States Advertising, Marketing & Sales

Farm Bill Would Boost USDA Organic Program Funding, Supply Chain Safety

Five-year reauthorization of USDA programs is controversial on numerous fronts because of its breadth. It includes programs from federal crop insurance to the Supplemental Nutrition Assistance Program, which accounts for 80% of the total spending. "As an industry, we need to be out there demonstrating support for the farm bill and why it’s so important for farmers to have that stability and consumers as well,” says Organic Trade Association executive Megan DeBates.

United States US States

Bayer Fortifies Branding In OTC Naproxen Market With Win In Trademark Litigation

Bayer convinces federal court to affirm USPTO appeal board decision to cancel competitor Belmora’s Flanax US naproxen product trademark because the firm used packaging that resembled a Bayer product with the same name sold in Mexico. The ruling could provide standing for owners of foreign marks to assert priority rights over similar US marks, according to a patent attorney.

International Mexico

Coppertone, One-A-Day Sales Slump As Bayer’s Consumer Health Slide Continues

Bayer reported consumer health sales globally fell 1.4% to $1.64bn after a late start to the allergy season drove down Claritin sales. Aleve analgesics sales grew 3.3% to $112.5m on US line extensions while Alka Seltzer line sales were flat at $47.5m.

Germany International

Church & Dwight Sees ‘A Lot Of Runway’ In US For Batiste Dry Shampoo

Market-leading Batiste is well-positioned for continued growth, given that 80% of women do not wash their hair every day and only 24% currently use dry shampoo. The brand’s US opportunity is particularly ripe, according to Executive VP and Chief Marketing Officer Britta Bohmard.

Commercial Business Strategies

Bayer’s Consumer Health Sales Stay Cool During Summer Months

Bayer reported consumer health sales globally fell 1.4% to $1.64bn after a late start to the allergy season drove down Claritin sales. Aleve analgesics sales grew 3.3% to $112.5m on US line extensions while Alka Seltzer line sales were flat at $47.5m.

Consumer Sales & Earnings
See All
Advertisement
UsernamePublicRestriction

Register